Search

everythinglearnresearchcommunity

for

Search:↓

After severe COVID-19, lung damage can improve, detected effectively by lung-ultrasound, and high pressure support during hospitalization can increase lung artery size. Also, about 22% of patients had lung blood clots, and when treated, they recovered faster.

The study found that PCOS affects about 6.5-6.8% of women in both urban and rural areas of Telangana, India, and highlighted the importance of lifestyle changes for management.

Micrografts are a safe and effective treatment for hair loss in both men and women.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Iron supplements may improve hair loss satisfaction even if initial iron levels are normal.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

AMT® is effective and safe for early-stage knee osteoarthritis.

No significant link between hair loss and iron or thyroid levels was found, but checking for deficiencies might still be useful.

Dr. SKS Hair Booster Serum effectively treats hair loss in women with PCOS.

The study concluded that Frontal fibrosing alopecia can affect younger people, is often missed in men, and may be autoimmune-related.

The supplement with amino acids, iron, selenium, and marine hydrolyzed collagen improved hair growth more than drug treatment alone, with most people tolerating it well.

Many women who have used performance-enhancing drugs in Finland show high rates of mental health and substance use issues, and most have normal red blood cell counts.

Women with Polycystic Ovary Syndrome are more likely to have Non-Alcoholic Fatty Pancreas Disease, which is associated with older age, metabolic syndrome, insulin resistance, and high male hormone levels.

COVID-19 patients with skin signs often stayed in the hospital for less time than those without skin signs.

Skin problems are common in kidney disease, with dry skin and itching in patients not on dialysis or on hemodialysis, and infections most common in transplant recipients.

Men with early onset hair loss are more likely to have high uric acid levels.

Female pattern hair loss in Saudi women is linked to low iron and vitamin D levels.

There is no link between hair loss and prostate enlargement.

People with hair loss conditions may also have thyroid disorders, but more research is needed to understand the connection.

Hyaluronic acid injections can improve mouth opening and quality of life in scleroderma patients.

The trial is testing if a helmet that uses light can prevent hair loss during chemotherapy.

Low vitamin D levels may affect ovulation and progesterone in infertile women.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

The main causes of diffuse hair loss in women are telogen effluvium and androgenetic alopecia, often related to stress and iron deficiency.

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

Most off-label drug prescriptions in Saudi Arabia are for adults with depression and diabetes.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Saw palmetto extract reduced hair loss and improved hair growth in people with hair thinning.